Effects of amitriptyline and mianserin on psychomotor skills and memory in man. 1978

M J Mattila, and R Liljequist, and T Seppälä

1. Twenty volunteers were treated with amitriptyline 25 mg, mianserin 10 mg, and placebo, three times daily for 2 weeks each, in a double-blind cross-over study. Tests of psychomotor function and of learning and memory, were carried out after consumption of alcohol or a placebo drink at intervals during each treatment period. 2. Coordinative and reactive skills were affected by mianserin on the first day only, but by amitriptyline up to day 7 in most of the tests. Both drugs seemed to interact additively with alcohol. 3. Amitriptyline impaired short-term memory span and acquisition, and alcohol enhanced these effects. Mianserin did not affect learning and memory, and did not interact with alcohol in this respect. 4. The differing effects of amitripyline and mianserin are considered in relation to anticholinergic properties.

UI MeSH Term Description Entries
D008297 Male Males
D008570 Memory, Short-Term Remembrance of information for a few seconds to hours. Immediate Recall,Memory, Immediate,Working Memory,Memory, Shortterm,Immediate Memories,Immediate Memory,Immediate Recalls,Memories, Immediate,Memories, Short-Term,Memories, Shortterm,Memory, Short Term,Recall, Immediate,Recalls, Immediate,Short-Term Memories,Short-Term Memory,Shortterm Memories,Shortterm Memory,Working Memories
D008803 Mianserin A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors. Lerivon,Mianserin Hydrochloride,Mianserin Monohydrochloride,Org GB 94,Tolvon,Hydrochloride, Mianserin,Monohydrochloride, Mianserin
D009048 Motor Skills Performance of complex motor acts. Motor Skill,Skill, Motor,Skills, Motor
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M J Mattila, and R Liljequist, and T Seppälä
January 1984, European journal of clinical pharmacology,
M J Mattila, and R Liljequist, and T Seppälä
January 1988, European journal of clinical pharmacology,
M J Mattila, and R Liljequist, and T Seppälä
December 1977, Pharmakopsychiatrie, Neuro-Psychopharmakologie,
M J Mattila, and R Liljequist, and T Seppälä
January 1978, The Journal of international medical research,
M J Mattila, and R Liljequist, and T Seppälä
January 1978, British journal of clinical pharmacology,
M J Mattila, and R Liljequist, and T Seppälä
December 1980, International journal of clinical pharmacology, therapy, and toxicology,
M J Mattila, and R Liljequist, and T Seppälä
January 1980, Progress in neuro-psychopharmacology,
M J Mattila, and R Liljequist, and T Seppälä
April 2001, Psychopharmacology,
M J Mattila, and R Liljequist, and T Seppälä
June 1976, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!